CDMO for EMBED 3.0 Research Study

Description

Due to the highly specific technical requirements regarding product manufacture (microinjection-moulding (MIM) of formulations containing API) it rapidly became clear that we needed to separate the production from the clinical trial services and identify separate vendors for these services. At the current stage of the program, the identification and selection of a Contract Development and Manufacturing Organization (CDMO) was prioritized by the EMBED team and the funder.